Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invigor Medical vs LillyDirect Foundayo

Invigor Medical
Graded #15

Higher grade

vs+18.89999999999999
LillyDirect Foundayo
Graded #165

Lower grade

The verdict

Invigor Medical takes it — 86.1/100 to 67.2/100.

Invigor Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. An established pharmacy operator with steady mid-market pricing and a broad catalog.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInvigor Medical +12
84
72
Dose & formulationInvigor Medical +25
84
59
Clinical oversightInvigor Medical +10
88
78
Labs & monitoringInvigor Medical +34
86
52
FulfillmentInvigor Medical +8
88
80
Contract termsInvigor Medical +35
90
55
Invigor Medical · left barLillyDirect Foundayo · right bar

The numbers

MetricInvigor MedicalLillyDirect Foundayo
WeighScore86.1/10067.2/100
GradeBC
Scorecard rank#15#165
Semaglutide$199/moNot disclosed
Tirzepatide$339/moNot disclosed
CoverageNot disclosedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Invigor Medical

Graded #15 · B

Strengths

  • Mid-market pricing on both molecules
  • Long-running operator

Where it loses points

  • No explicit states list
  • Compounded only
LillyDirect Foundayo

Graded #165 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard